Feature Channels:

Stem Cells

Add to Favorites | Subscribe | Share

Filters:

  • (Press "esc" to clear)

Medicine

Channels:

Metabolic Vulnerability of Certain Breast Cancers, Radiosurgery for Brain Cancer, Measuring Radiation Therapy, and More in the Cancer News Source

Click here to go directly to the Cancer News Source

Medicine

Channels:

Stem Cell, Stem Cell Research, Muscular dystrophies, Muscular Disorders, Muscular Dystrophy Research, muscular dystrophy treatments, Duchene muscular dystrophy, Duchenne muscular dystrophy treatments, muscle stem cells, cell therapies, Cell Therapy, Cell Replacement Therapy

UCLA Researchers Create Skeletal Muscle From Stem Cells

ERBB3NGFRvs.previousmethods_800x533.jpg

UCLA scientists have developed a new strategy to efficiently isolate, mature and transplant skeletal muscle cells created from human pluripotent stem cells, which can produce all cell types of the body. The findings are a major step towards developing a stem cell replacement therapy for muscle diseases including Duchenne Muscular Dystrophy.

Medicine

Channels:

Stomach Cancer, H Pylori, Metaplasia, Chief Cells

Study Prompts New Ideas on Cancers’ Origins

Cancer therapies often target cells that grow and divide rapidly, such as stem cells, but in studying how stomach cancers occur, researchers at Washington University School of Medicine in St. Louis found that even when the stomach isn't able to make stem cells, other cells in the stomach can begin to divide and contribute to precancerous lesions.

Medicine

Channels:

Bipolar Disorder, Stem Cells, Manic Depression, Mental Health, longitudinal studies , bipolar

After Searching 12 Years for Bipolar Disorder’s Cause, Team Concludes It Has Many

Nearly 6 million Americans have bipolar disorder, and most have probably wondered why. After more than a decade of studying over 1,100 of them in-depth, a team of scientists has an answer – or rather, seven answers.

Medicine

Channels:

Retinitis Pigmentosa, Vision Loss, Stem Cells, California Institute For Regenerative Medicine, retinal progenitor cells

Results of Clinical Testing in Retinitis Pigmentosa

In a phase 1/2a study jCyte's investigational therapy, jCell, showed a good safety profile and indications of potential benefit for patients with retinitis pigmentosa

Medicine

Channels:

MS Research, Multiple Sclerosis (MS)

Barancik Prize To Be Presented at ACTRIMS Forum 2018

ProfessorRobinFranklin.jpg

Professor Robin Franklin to receive the 2017 Barancik Prize for pioneering work to restore function for people with progressive MS. He will receive the award at ACTRIMS Forum 2018 on February 1 in San Diego, California.

Medicine

Science

Channels:

muscle stem cells, skeletal muscle, Muscular Diseases, Muscular dystrophies, Aging, tissue damage, MUSCLE ATROPHY

Researchers Track Muscle Stem Cell Dynamics in Response to Injury and Aging

A new study led by SBP describes the biology behind why muscle stem cells respond differently to aging or injury. The findings, published in Cell Stem Cell, have important implications for the normal wear and tear of aging.

Science

Channels:

Stem Cells, Cancer, Biochemistry & Biophysics, Pharmacology

What Keeps Stem Cells in Their Undifferentiated State?

COOK_MATSON_differentiatingstemcells_edited.jpg

A special cluster of proteins helps unwind DNA during cell division and plays a key role in keeping stem cells in their immature state. This UNC study also points to a better understanding of how cancer cells manage to sustain rapid cell division without triggering cell death.

Medicine

Channels:

Lymphoma treatment, Lymphoma

Combination Immunotherapy Shown to Be Effective Initial Treatment for Relapsed or Refractory Hodgkin Lymphoma

herrera-alex.jpg

For many people with classical Hodgkin lymphoma, the disease is one of the most curable forms of cancer with standard chemotherapy or chemo plus radiotherapy. But for the 10 to 30 percent of patients whose cancer relapses, or doesn’t respond to initial therapy, secondary treatment often involves harsher chemotherapies followed by an autologous stem cell transplant, which uses a patient’s own stem cells.

Medicine

Channels:

Disparities, Stem Cell Therapy, Multiple Myeloma

Study Identifies Barriers to Transplant Therapy to Treat Multiple Myeloma Among Racial Minority Groups

A study by researchers at Mayo Clinic’s campus in Jacksonville, Florida has found that barriers to patients receiving stem cell therapy as part of their treatment for multiple myeloma include income, education, insurance status and access to care at an academic center or facility that treats a high volume of patients.







Chat now!